ArticleJournal of contemporary brachytherapy2025
Clinical and dosimetric outcomes of carcinoma cervix patients treated with MRI only at first fraction, followed by CT-based image-guided brachytherapy for subsequent fractions.
Article in Journal of contemporary brachytherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review.Journal of contemporary brachytherapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Magnetic resonance (MRI)-based image-guided brachytherapy (IGBT) is the gold standard technique for carcinoma cervix. We aimed to evaluate doses to target and organs at risk (OARs), and report clinical outcomes of locally advanced carcinoma cervix (LACC) patients treated with a hybrid approach of using MRI- and computed tomography (CT)-based IGBT. Material and methods: Twenty-two LACC patients, after receiving external beam radiotherapy of 50 Gy in 25 fractions with concurrent cisplatin 40 mg/m Results: The median age was 50 years. Fourteen (63.6%) patients were FIGO (2010) stage II. HR-CTV volumes (mean ±SD) of MRI, CT-1, and CT-2 were 24.23 cc ±9.26 cc, 27.82 cc ±15.37 cc, and 24.82 cc ±11.14 cc, respectively ( Conclusions: Hybrid approach in IGBT using MRI at first fraction and CT for subsequent fractions yields comparable dosimetric parameters and decent long-term clinical outcomes. This approach could be considered resource-sparing brachytherapy technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.